Danaher Corporation $DHR Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC lowered its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 11.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,442,791 shares of the conglomerate’s stock after selling 184,915 shares during the period. Hsbc Holdings PLC owned about 0.20% of Danaher worth $330,516,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of the stock. Bank Pictet & Cie Europe AG boosted its position in Danaher by 25.4% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 366,481 shares of the conglomerate’s stock worth $83,895,000 after acquiring an additional 74,301 shares during the last quarter. Maxi Investments CY Ltd acquired a new stake in Danaher in the 3rd quarter valued at about $3,251,000. Northwestern Mutual Wealth Management Co. lifted its stake in Danaher by 303.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock worth $56,777,000 after purchasing an additional 186,584 shares in the last quarter. Defender Capital LLC. purchased a new position in Danaher in the 4th quarter worth approximately $35,715,000. Finally, CIBC Bancorp USA Inc. acquired a new position in shares of Danaher during the 3rd quarter worth approximately $17,480,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Up 0.3%

Shares of NYSE DHR opened at $177.74 on Friday. The company has a market capitalization of $125.80 billion, a P/E ratio of 34.38, a P/E/G ratio of 2.26 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a 50 day simple moving average of $179.62 and a 200-day simple moving average of $203.07. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same period in the prior year, the firm posted $1.88 earnings per share. On average, equities research analysts predict that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s payout ratio is currently 30.95%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on DHR shares. HSBC dropped their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Barclays reduced their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. DZ Bank began coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective on the stock. Wells Fargo & Company cut their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Finally, Royal Bank Of Canada initiated coverage on Danaher in a report on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $233.61.

Read Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.